Key drivers of 90-day costs in primary total elbow arthroplasty

Seminars in Arthroplasty: JSES - Tập 33 - Trang 775-781 - 2023
Kaitlyn A. Rodriguez1, Jay M. Levin1, Mikhail Bethell1, Prince Boadi1, Eoghan T. Hurley1, Kier Blevins1, Tyler Pidgeon1, Marc Richard1, David Ruch1, Oke Anakwenze1, Christopher S. Klifto1
1Department of Orthopedic Surgery, Duke University School of Medicine, Durham, NC, USA

Tài liệu tham khảo

Black, 2013, Value-based shoulder surgery: practicing outcomes-driven, cost-conscious care, J Shoulder Elbow Surg, 22, 10.1016/j.jse.2013.02.008 Carducci, 2020, Variation in the cost of care for different types of joint arthroplasty, J Bone Joint Surg Am, 102, 404, 10.2106/JBJS.19.00164 Charlson, 1987, A new method of classifying prognostic comorbidity in longitudinal studies: development and validation, J Chronic Dis, 40, 373, 10.1016/0021-9681(87)90171-8 Davis, 2014, Factors affecting hospital charges after total shoulder arthroplasty: an evaluation of the national inpatient sample database, J Shoulder Elbow Surg, 23, 1860, 10.1016/j.jse.2014.04.002 Day, 2010, Prevalence and projections of total shoulder and elbow arthroplasty in the United States to 2015, J Shoulder Elbow Surg, 19, 1115, 10.1016/j.jse.2010.02.009 Furman, 2020, Differences in 30-day outcomes between inpatient and outpatient total elbow arthroplasty (TEA), J Shoulder Elbow Surg, 29, 2640, 10.1016/j.jse.2020.06.009 Gay, 2012, Indications and reoperation rates for total elbow arthroplasty: an analysis of trends in New York State, J Bone Joint Surg Am, 94, 110, 10.2106/JBJS.J.01128 Lovy, 2016, Outcomes, complications, utilization trends, and risk factors for primary and revision total elbow replacement, J Shoulder Elbow Surg, 25, 1020, 10.1016/j.jse.2015.12.012 Malik, 2020, Current diagnosis-related group-based bundling for upper-extremity arthroplasty: a case of insufficient risk adjustment and misaligned incentives, J Shoulder Elbow Surg, 29, e297, 10.1016/j.jse.2019.12.029 Maradit Kremers, 2015, Prevalence of total hip and knee replacement in the United States, J Bone Joint Surg Am, 97, 1386, 10.2106/JBJS.N.01141 McKee, 2009, A multicenter, prospective, randomized, controlled trial of open reduction--internal fixation versus total elbow arthroplasty for displaced intra-articular distal humeral fractures in elderly patients, J Shoulder Elbow Surg, 18, 3, 10.1016/j.jse.2008.06.005 Menendez, 2018, Time-driven activity-based costing to identify patients incurring high inpatient cost for total shoulder arthroplasty, J Bone Joint Surg Am, 100, 2050, 10.2106/JBJS.18.00281 Meyers, 1996, Inpatient cost of primary total joint arthroplasty, J Arthroplasty, 11, 281, 10.1016/S0883-5403(96)80079-9 Nicholson, 2021, Cost-effectiveness of the reverse total shoulder arthroplasty. Does indication affect outcome?, Shoulder Elbow, 13, 90, 10.1177/1758573219897860 Pappou, 2014, Outcomes and costs of reverse shoulder arthroplasty in the morbidly obese: a case control study, J Bone Joint Surg Am, 96, 1169, 10.2106/JBJS.M.00735 Pasternack, 2019, The transition of total elbow arthroplasty into the outpatient theater, JSES Int, 4, 44, 10.1016/j.jses.2019.10.004 Prkić, 2016, Total elbow arthroplasty is moving forward: review on past, present and future, World J Orthop, 7, 44, 10.5312/wjo.v7.i1.44 Rana, 2015, Bundled payments in orthopaedics, Clin Orthop Relat Res, 473, 422, 10.1007/s11999-014-3520-2 Rosas, 2017, Comorbidity effects on shoulder arthroplasty costs analysis of a nationwide private payer insurance data set, J Shoulder Elbow Surg, 26, e216, 10.1016/j.jse.2016.11.044 Toor, 2014, Comparison of perioperative complications after total elbow arthroplasty in patients with and without diabetes, J Shoulder Elbow Surg, 23, 1599, 10.1016/j.jse.2014.06.045 2020 Wickman, 2022, Influence of medical comorbidity and surgical indication on total elbow arthroplasty cost of care, J Shoulder Elbow Surg, 31, 1884, 10.1016/j.jse.2022.02.038 Zhang, 2019, Total elbow arthroplasty, J Hand Surg Am, 44, 487, 10.1016/j.jhsa.2018.11.005 Zhou, 2016, Total elbow arthroplasty in the United States: evaluation of cost, patient demographics, and complication rates, Orthop Rev, 8, 6113